Skip to main content

Seizinger Bernd R.'s Form 4 filing

Aprea Therapeutics, Inc.APRE · filed Mar 14, 2024

Accession no.
0001104659-24-034672
Filed
Mar 14, 2024
Trade date
Mar 13, 2024
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $50.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Seizinger Bernd R.CIK 0001789042Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 13, 2024Common StockPPurchaseAcquired+6,860$7.29+$50,009.433,685Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 13, 2024Common StockPPurchaseAcquired+3,430–F3–3,430Direct
Mar 13, 2024Common StockPPurchaseAcquired+3,430–F6–3,430Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The purchase price for the Tranche A Warrants is included in the purchase price for the shares of Common Stock reflected in Table I above.

Referenced by the price of 1 transaction in Table II.

F6

The purchase price for the Tranche B Warrants is included in the purchase price for the shares of Common Stock reflected in Table I above.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)